The Impact of C-Met Expression on the Immune Microenvironment and Survival in Locally Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Xu, Xu. [1 ]
Xu, X. [1 ]
Zhu, Y. [1 ]
Ye, L. [2 ]
Zhang, Y. [1 ]
Zhang, W. [1 ]
Wu, L. [1 ]
Wu, C. [1 ]
Xu, Y. [1 ]
机构：
[1] Shanghai Pulm Hosp, Shanghai, Peoples R China
[2] Wenzhou Med Univ, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Non-Small Cell Lung Cancer; Immune Microenvironment; cMET;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.08B.02
引用
收藏
页码：S566 / S566
页数：1
相关论文
共 50 条
  • [21] Mechanism of EGFR and c-Met TKI resistance and role of co-expression of EGFR and c-Met in non-small cell lung cancer patients
    Botting, Gregory Michael
    Harrington, Kymberly
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Arasi, Kavin
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Ma, Haichun
    Zhao, Yutong
    ONCOLOGY RESEARCH, 2020, 28 (05) : 497 - 507
  • [23] Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer
    Han, Zhaoguo
    Xiao, Yadi
    Wang, Kai
    Yan, Ji
    Xiao, Zunyu
    Fang, Fang
    Jin, Zhongnan
    Liu, Yang
    Sun, Xilin
    Shen, Baozhong
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (11) : 1686 - 1691
  • [24] Immune microenvironment composition in non-small cell lung cancer and its association with survival
    Tamminga, Menno
    Hiltermann, Thijo Jeroen N.
    Schuuring, Ed
    Timens, Wim
    Fehrmann, Rudolf S. N.
    Groen, Harry J. M.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (06)
  • [25] Immune Parameters as Predictors of Pneumonitis and Survival in Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation
    Ho, Quoc-Anh
    Qi, Lihong
    Rao, Shyam S.
    Daly, Megan E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E36 - E37
  • [26] MET alterations in advanced non-small cell lung cancer
    Sakamoto, Mandy
    Patil, Tejas
    LUNG CANCER, 2023, 178 : 254 - 268
  • [27] MET alterations in advanced non-small cell lung cancer
    Chagas, Gabriel Cavalcante Lima
    Rangel, Amanda Ribeiro
    El Osta, Badi
    CURRENT PROBLEMS IN CANCER, 2024, 49
  • [28] Telisotuzumab vedotin monotherapy in patients with previously treated c-Met plus advanced non-small cell lung cancer
    Horinouchi, Hidehito
    Goldman, J. W.
    Moiseenko, F.
    Cicin, I.
    Filippova, E.
    Bar, J.
    Tomasini, P.
    Ocampo, C.
    Sullivan, D.
    Maag, D.
    Motwani, M.
    Jin, J.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2022, 33 : S502 - S502
  • [29] Survival data in elderly patients with locally advanced non-small cell lung cancer
    Domingues, Pedro Masson
    Zylberberg, Ricardo
    de Castro, Thalita da Matta
    Baldotto, Clarissa Serodio
    de Lima Araujo, Luiz Henrique
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [30] Trading treatment toxicity for survival in locally advanced non-small cell lung cancer
    Brundage, MD
    Davidson, JR
    Mackillop, WJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 330 - 340
12345